Clinical Trials Logo

Aneurysm, Dissecting clinical trials

View clinical trials related to Aneurysm, Dissecting.

Filter by:

NCT ID: NCT03233087 Recruiting - Aortic Aneurysm Clinical Trials

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Start date: March 1, 2014
Phase:
Study type: Observational

The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.

NCT ID: NCT03010514 Recruiting - Clinical trials for Aortic Aneurysm, Thoracic

A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection

ARSGBTAAD
Start date: October 2016
Phase: N/A
Study type: Observational

This is a national registry study to determine genetic risk factor and serial biomarkers of thoracic aortic aneurysm/dissection

NCT ID: NCT02953405 Recruiting - Clinical trials for MCA - Middle Cerebral Artery Dissection

Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

Start date: December 2015
Phase: N/A
Study type: Observational

Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.

NCT ID: NCT02914288 Recruiting - Clinical trials for Cerebral Arterial Diseases

Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI

Start date: April 2016
Phase: N/A
Study type: Observational

Intracranial artery disease has been more detected with development of HR-MR. HR-MR can depict vascular wall directly and give us more information beyond the pre-existing imaging modalities such as digital subtraction angiography, magnetic resonance angiography, computed tomography angiography. Hence, HR-MR is considered to become promising imaging modality for intracranial artery disease and many studies have been published recently. However, there was not enough to differentiate various intracranial artery disease such as atherosclerosis, dissection, moyamoya disease, vasculitis, reversible vasoconstriction syndrome. In real clinical arena, intracranial artery disease is too difficult to diagnose and distinguish among the disease. Of the disease, usefulness of HR-MR has been consistently published in the detection and diagnosis of intracranial artery dissection recently. HR-MR seems to be the most important and reliable imaging method in intracranial artery dissection as of now. Therefore, intracranial artery dissection is necessary to study using HR-MR. Intracranial artery dissection is dynamic vascular pathology. The geometric change is the most common among intracranial artery disease. However, there was no report about the geometric change in HR-MR. The investigators acquired retrospective data about the natural course of intracranial artery dissection in HR-MR and are preparing for publishing an article. However, the data is not prospective and not intraindividual comparison. Therefore, reliability is not enough to convince the natural course. If the investigators got prospective and intraindividual data, definite natural course of intracranial artery dissection could be acquired and would be helpful to diagnose the dissection and differentiate from other vascular pathologies. The prospective longitudinal information from this study could guide us as the important map on the confusing HR-MR findings. The protocols for imaging are as follows: initial (optional), 1 month, 3 month, 6 month (optional), 12 month.

NCT ID: NCT02622542 Recruiting - Clinical trials for Distal Aortic Dissection

ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy

ACUTE-B
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair (BMT+TEVAR) for uncomplicated acute type B aortic dissection.